Skip to content

Fast-track Giant Ventral Hernia Repair

Fast-track Giant Ventral Hernia Repair

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02305082
Enrollment
32
Registered
2014-12-02
Start date
2014-12-31
Completion date
2015-07-31
Last updated
2015-09-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hernia, Ventral

Brief summary

The implementation of an enhanced recovery pathway after giant ventral hernia repair, including preoperative high-dose steroid is examined prospectively and compared with a group of historic controls.

Detailed description

All patients operated on for a large incisional hernia are treated according to the study protocol. Patients are given high-dose glucocorticoid preoperative and the aim is to discharge patients at postoperative day 3. Morbidity, length of stay, pain, nausea and pulmonary function are among registered outcomes compared with a historic control group.

Interventions

OTHERFast-track group

Enhanced recovery after surgery pathway. Postoperatively, a set of well-defined discharge criteria will be assessed daily at 9:00 and 15:00, as well as pain, nausea, time to flatus, saturation and drain production.

Sponsors

Bispebjerg Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Horizontal fascia defect \> 10 cm on computed tomography scan * Planned elective open incisional hernia repair

Exclusion criteria

* Known allergy against glucocorticoid treatment * Insulin-treated diabetes * Gastric ulcer diagnosed within four weeks preoperative * Steroid-treated immune disease * Planned intestinal anastomosis concomitant to hernia repair

Design outcomes

Primary

MeasureTime frameDescription
Time to dischargeParticipants will be followed for the duration of hospital stay, an expected average of 72 hoursTime from surgery to discharge \[Hours\].

Secondary

MeasureTime frameDescription
Detailed reason for not being discharged if criteria are otherwise fulfilledFrom surgery and for the duration of hospital stay, an expected average of 3 daysThe reason(s) for participants not being discharged if discharge criteria are otherwise fulfilled.
FatiguePreoperative and for the duration of hospital stay, an expected average of 3 daysPreoperative and twice daily (9 and 15) postoperative. Measured by a numerical rating scale (1 = No fatigue, 5 = Exhausted).
Pain from supine to standingPreoperative and for the duration of hospital stay, an expected average of 3 daysPreoperative and twice daily (9 and 15) postoperative. Measured by a numerical rating scale (1 = No pain, 5 = Intolerable pain)
Pain when walking 6 metersPreoperative and for the duration of hospital stay, an expected average of 3 daysPreoperative and twice daily (9 and 15) postoperative. Measured by a numerical rating scale (1 = No pain, 5 = Intolerable pain)
NauseaPreoperative and for the duration of hospital stay, an expected average of 3 daysPreoperative and twice daily (9 and 15) postoperative. Measured by a numerical rating scale (1 = No nausea, 5 = Intolerable nausea)
Daily wound drain productionFrom surgery and for the duration of hospital stay, an expected average of 3 daysDaily registration of the fluid volume \[milliliters\] in the wound drains postoperative.
Vomiting episodesParticipants will be followed for the duration of hospital stay, an expected average of 3 daysThe daily number of vomiting episodes will be registered for each participant
Continuous transcutaneous saturationFrom surgery to postoperative day 3 at 12 pmContinuous transcutaneous oxygen saturation (percentage), measured by Pulsox 300i (C) (Konica Minolta, Osaka, Japan)
C-reactive protein from venous blood samplePreoperative and for the duration of hospital stay, an expected average of 3 daysDaily C-reactive protein measured in a venous blood sample.
Ear temperaturePreoperative and for the duration of hospital stay, an expected average of 3 daysEar temperature (celsius degree) measured daily at 9 and 15.
Time to bowel functionFor the duration of postoperative hospital stay, an expected average of 72 hoursThe time to bowel function \[hours\] will be registered for each participant

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026